Disc Medicine IRON Cash Flow Statement (2020-2026)

NASDAQ IRON
$79.80 +0.43 (+0.54%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Disc Medicine Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Disc Medicine reported cash from operations of -$44.20M and free cash flow of -$44.20M for the quarter ended Jun 2026, up 7.8% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18.55M20.25M-9.85M-9.58M-16.15M-11.24M-22.86M-15.92M-14.10M-23.55M-27.04M-26.35M-26.60M-29.44M-34.09M-55.25M-62.32M-16.02M-63.55M-59.53M
Share-based Compensation
10.57M-4.44M0.33M0.38M0.38M0.99M1.02M1.31M2.56M1.93M4.06M4.09M4.33M4.33M6.36M8.42M9.51M10.04M11.95M13.95M
Gains from Investment Securities
Cash from Operations
-16.10M19.50M-13.70M-9.19M-9.69M-9.66M-35.47M-12.72M-7.48M-17.80M-33.60M-15.39M-17.36M-27.57M-41.38M-47.92M-47.80M-43.30M-62.24M-44.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.60M2.50M2.21M2.53M2.62M1.74M1.63M1.07M0.49M
Depreciation & Amortization (CF)Depreciation & Amortization
0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M0.11M0.01M0.01M0.02M0.09M0.09M0.09M0.09M0.09M
Change in Working Capital
Change in Account Payables
-0.50M1.77M-0.98M1.99M-0.40M-0.07M-10.75M-0.73M3.77M3.97M-7.36M-0.67M-1.05M4.39M-1.28M-0.32M0.92M1.75M2.74M-4.92M
Change in Accured Expenses
1.71M-0.05M-0.02M-0.90M0.45M1.97M-2.08M0.29M0.94M2.69M-3.09M0.96M1.48M2.33M-3.69M1.17M4.95M4.45M-8.73M2.05M
Change in Taxes
Other Working Capital Changes
0.83M-2.73M-3.19M5.05M-0.17M-2.04M0.91M-1.05M-0.20M1.51M4.11M-2.50M-1.11M-2.08M7.23M0.68M-0.37M1.38M4.55M-2.28M
Investing Activities
Capital Expenditures
0.01M0.10M0.02M0.02M0.01M0.03M0.01M0.04M0.00M0.07M-0.00M-0.01M0.45M0.85M0.04M0.03M0.02M
Change in Acquisitions & Divestments
23.00M71.80M75.47M110.35M135.00M135.40M152.07M114.36M
Cash from Investing Activities
-0.01M-0.10M-0.02M-0.02M-0.01M-0.03M-0.01M-0.04M-0.00M-0.07M-219.75M-71.09M-1.43M-272.63M51.69M49.54M-222.89M58.31M21.63M
Financing Activities
Other financing activities
-195.81M0.06M0.09M0.02M0.06M0.22M1.08M0.62M0.81M0.81M0.57M0.40M1.20M0.57M0.89M1.53M5.64M1.01M2.36M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
5.06M0.98M0.06M0.24M0.62M0.90M1.06M
Net Equity Issued and Repurchased
34.22M-20.00M
Misc.
Cash from Financing Activities
-1.25M-102.73M0.06M0.09M0.02M148.81M77.31M153.85M0.46M7.76M15.90M173.19M0.43M28.80M244.25M0.89M11.59M216.68M1.70M32.34M
Change in Cash
-17.41M-83.24M13.75M-36.62M-9.69M139.14M41.81M141.12M-7.06M-10.04M-17.77M-61.95M-88.03M-0.20M-69.76M4.66M13.33M-49.52M-2.23M9.76M
Free Cash Flow
-16.10M19.49M-13.80M-9.21M-9.71M-9.68M-35.49M-12.74M-7.52M-17.80M-33.67M-15.39M-17.35M-28.02M-42.23M-47.95M-47.83M-43.32M-62.24M-44.20M
Net Cash Flow
-17.35M-83.24M-13.75M-9.13M-9.69M139.14M41.81M141.12M-7.06M-10.04M-17.77M-61.95M-88.03M-0.20M-69.76M4.66M13.33M-49.52M-2.23M9.76M